Inhibition of the Na+/H+ exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs

Circulation

Volumn 100, Issue 25, 1999, Pages 2519-2526

  Gumina, R J ^a   Buerger, E ^a   Eickmeier, C ^a   Moore, J ^a   Daemmgen, J ^a   Gross, G J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Ions; Ischemia; Myocardial infarction

Indexed keywords

(METHYLSULFONYL)METHANESULFONATE; 5 (N ETHYL N ISOPROPYL)AMILORIDE; AMILORIDE; ANTIPORTER; CARIPORIDE; MESYLIC ACID DERIVATIVE; N (AMINOIMINOMETHYL) 4 [4 (2 FURANYLCARBONYL) 1 PIPERAZINYL] 3 BENZAMIDE; UNCLASSIFIED DRUG; [4 [4 (2 FUROYL) 1 PIPERAZINYL] 3 (METHYLSULFONYL)BENZOYL]GUANIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE;

EID: 0033613553     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.25.2519     Document Type: Article

References (36)